Hsa_circRNA_0040462: a sensor of cells' response to CAP treatment with double-edged roles on breast cancer malignancy

Tian, Yue; Zhang, Zhifa; Zhang, Zijing; Dai, Xiaofeng

doi:10.7150/ijms.66940



Theranostics

International Journal of Biological Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Med Sci 2022; 19(4):640-650. doi:10.7150/ijms.66940 This issue Cite

Research Paper

Hsa_circRNA_0040462: a sensor of cells' response to CAP treatment with double-edged roles on breast cancer malignancy

Yue Tian^1#, Zhifa Zhang¹, Zijing Zhang¹, Xiaofeng Dai^1#✉

1. Wuxi School of Medicine, Jiangnan University, Wuxi, 214122, China.
2. CAPsoul Medical Biotechnology Company, Ltd., Beijing, 100000, China.
#These authors contribute equally to this work.

Citation:

Tian Y, Zhang Z, Zhang Z, Dai X. Hsa_circRNA_0040462: a sensor of cells' response to CAP treatment with double-edged roles on breast cancer malignancy. Int J Med Sci 2022; 19(4):640-650. doi:10.7150/ijms.66940. https://www.medsci.org/v19p0640.htm

Other styles

Abstract

Cold atmospheric plasma (CAP) represents a novel onco-therapeutic approach that has demonstrated its efficacy in many types of tumors. The efficacy of CAP is dose-dependent that determines the panel of tumors feasible for receiving CAP treatment under a certain parameter configuration. Identifying markers for easy and fast prognosis of tumors' sensitivity in response to CAP exposure is of critical value towards optimized therapeutic outcome, the lack of which has largely limited the translation of CAP into clinics. Circular RNAs represent a novel type of biomarkers for disease diagnosis that is featured by easy detection and stability. Through whole transcriptome sequencing, followed by in vitro validations, computational predictions and preliminary functional studies, we identified hsa_circRNA_0040462 as a sensor of breast cancer cells' response to CAP treatment. Yet we warrant the use of hsa_circRNA_0040462 as an onco-therapeutic target given its double-edged roles on breast cancer progression, i.e., suppressive on the growth and promotive on the migrative ability of triple negative breast cancer cells. Our study for the first time focused on markers prognostic of CAP's efficacy and tumors' sensitivity to CAP treatment under a certain parameter configuration, and reported hsa_circRNA_0040462 as a sensor of cells' response to CAP treatment. Also, the uncovered dual roles of hsa_circRNA_0040462 further advanced our knowledge on the complex yet critical regulatory functionalities of circular RNAs in cancer progression.

Keywords: triple negative breast cancer, circular RNA, cold atmospheric plasma, epigenetics

Citation styles

APA

Tian, Y., Zhang, Z., Zhang, Z., Dai, X. (2022). Hsa_circRNA_0040462: a sensor of cells' response to CAP treatment with double-edged roles on breast cancer malignancy. International Journal of Medical Sciences, 19(4), 640-650. https://doi.org/10.7150/ijms.66940.

ACS

Tian, Y.; Zhang, Z.; Zhang, Z.; Dai, X. Hsa_circRNA_0040462: a sensor of cells' response to CAP treatment with double-edged roles on breast cancer malignancy. Int. J. Med. Sci. 2022, 19 (4), 640-650. DOI: 10.7150/ijms.66940.

NLM

CSE

Tian Y, Zhang Z, Zhang Z, Dai X. 2022. Hsa_circRNA_0040462: a sensor of cells' response to CAP treatment with double-edged roles on breast cancer malignancy. Int J Med Sci. 19(4):640-650.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.